The Filing Desk

AirSculpt Technologies vs biote

AirSculpt Technologies AIRS · biote BTMD · Health Care Services

biote reported revenue of $192 million in fiscal 2025, 1.3 times AirSculpt Technologies' $152 million in fiscal 2025. AirSculpt Technologies' revenue fell 15.8% in its latest year, and biote's fell 2.5%. AirSculpt Technologies had an operating margin of -7.6%, against 18.5% at biote. Free cash flow was $1 million at AirSculpt Technologies and $30 million at biote.

Side by side

AirSculpt Technologiesbiote
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$152M$192M
Revenue growth−15.8%−2.5%
Revenue growth a year, last 5 years19.3%—
Gross margin——
Operating margin−7.6%18.5%
Net margin−7.7%14.1%
Free cash flow$1M$30M
Free cash flow margin0.5%15.7%
Return on capital−6.6%—
Net debt to EBITDA39.0x2.0x
Dividends and buybacks$0M$5M
Change in diluted share count4.8%7.0%
Last close$0.65$0.84
P/E at the last close——
Insider trades, last 12 monthsbought $2.0 million, sold $0bought $202,204, sold $0
Piotroski F-score3 of 85 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AirSculpt Technologiesbiote
Operating margin
Percent of revenue
AirSculpt Technologiesbiote
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AirSculpt Technologiesbiote

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AirSculpt Technologies and biote pages.